Kalehua Capital Management »

Surrozen shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 385k 29.13

More positions owned by Kalehua Capital Management

Alpha Architect 1-3 Month Box ETF Alpha Arch 1-3 (BOXX)
X4 Pharmaceuticals Com New (XFOR)
Surrozen Com New (SRZN)
Veradermics Common Stock
Relay Therapeutics (RLAY)
Sionna Therapeutics (SION)
Aclaris Therapeutics (ACRS)
Inhibikase Therapeutics Com New (IKT)
Oruka Therapeutics (ORKA)
Pharvaris N V (PHVS)
Uniqure NV SHS (QURE)
Septerna (SEPN)
Compass Pathways Sponsored Ads (CMPS)
Athira Pharma (LONA)
Damora Therapeutics Com New (DMRA)

View all positions for Kalehua Capital Management

Top funds holding Surrozen

TCG Crossover Management
Millennium Management
VR Adviser
Stempoint Capital
Boxer Capital Management
Braidwell
5AM Venture Management
Kalehua Capital Management
Vestal Point Capital
Vanguard Group
Vivo Capital
Perceptive Advisors
Woodline Partners
Balyasny Asset Management
Ikarian Capital

View all funds holding Surrozen